| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.09 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.093 | 0.09 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.055 | 0.09 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.088 | 0.09 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.09 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.059 | 0.09 |